Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer
about
Low-Dose Cadmium Exposure Reduces Human Prostate Cell Transformation in Culture and Up-Regulates Metallothionein and MT-1G mRNAThe immortalized UROtsa cell line as a potential cell culture model of human urotheliumMetallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosisDifferential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.Identification of genes associated with multiple cancers via integrative analysis.Simple method for identification of metallothionein isoforms in cultured human prostate cells by MALDI-TOF/TOF mass spectrometryProfiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.Cross-species hybridization of woodchuck hepatitis virus-induced hepatocellular carcinoma using human oligonucleotide microarrays.Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells.Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions.Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining.Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.The roles of metallothioneins in carcinogenesis
P2860
Q24310858-CB8F8F56-D408-42F4-936B-AB3CCD33AF54Q24813017-E4B3997F-1477-4F0F-A5DD-EA9F4514B73FQ28343512-C0468626-AD91-4D2E-8783-AF52772277E0Q30336222-98FF6833-1257-4B34-A014-582B81504F7BQ30887744-FF0FE1D7-CBE7-4953-BD15-C5D72A65FB2BQ33284428-68CF86FB-DBFF-4BF3-B6CA-C6983F8A0AE8Q33649966-991ACD37-C1D5-41CC-BB24-B4872AE5DB5BQ33867817-91ECD489-174D-484F-BFBB-F30838425775Q34122287-6CB9AE5B-30DB-47C3-9061-7B4B5FC69F58Q35770397-F5C21CB9-1277-4E9A-AF42-F22CA168AFD3Q36085432-3A7498CF-96B4-492F-9E6F-70163036100CQ37002626-8EB2535C-F21E-45C5-9E28-776A7CA22A77Q37724698-E9BFC7A9-A8D8-46BB-92BD-C7F56599BCA1Q40022364-9A1275E4-5C04-41CB-9041-C70602FDE50CQ44871312-0F061A62-F614-4BE6-8A4B-155BFE55C3FDQ58713688-0B4E546A-B550-42F3-88BC-B2D1BDA750FD
P2860
Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer
description
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: May 2000)
@en
vedecký článok (publikovaný 2000/05/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/05/01)
@nl
наукова стаття, опублікована в травні 2000
@uk
مقالة علمية (نشرت في مايو 2000)
@ar
name
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@ast
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@en
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@nl
type
label
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@ast
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@en
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@nl
prefLabel
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@ast
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@en
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@nl
P2093
P1433
P1476
Metallothionein isoform 1 and ...... 1X in advanced prostate cancer
@en
P2093
S H Garrett
P304
P356
10.1002/(SICI)1097-0045(20000501)43:2<125::AID-PROS7>3.3.CO;2-J
P407
P577
2000-05-01T00:00:00Z